What does CJC-1295 stand for?
This site's CJC-1295 profile does not treat the letters as short for anything. CJC-1295 is a lab code for a changed version of growth hormone releasing hormone. DAC, listed as another name, stands for Drug Affinity Complex. It is an add-on that sticks to albumin, a blood protein, which stretches out its half-life. Two 2006 studies in healthy adults put that half-life at 5.8 to 8.1 days. They found one shot raised average growth hormone two- to tenfold for six days or more. Neither version is FDA approved. The letters are a code, not a ranking and not a dose.
Studies in people from the compound pages this answer belongs to
- CJC-1295
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults 2006 PMID 16352683
- Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog 2006 PMID 17018654
- A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity 2005 NCT00267527
Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.
Part of further names and published absences. Leftover harvested questions after the first two absence sets: more brand versus molecule names, side effects the citations did not count, compounding formulas this catalogue does not hold, national FDA and Australia fields, trial windows rather than an onset clock, named combinations with no interaction table, and oral routes that have not been studied.